[Abstract] Hepatitis B virus (HBV) mutants can lead to vaccine failure, diagnostic failure of HBV detection, increase viral replication and resistance to antiviral agents. To study the biological characteristics of these mutations may contribute to our knowledge on viral pathogenesis. Therefore, it is essential to isolate and characterize HBV strains from patients.
Example: For a 1% gel slice equivalent to 100 μl, add the following:
• 300 μl Buffer DE-A
• 150 μl Buffer DE-B
If the DNA fragment is <400 bp, you would also add:
• 100 μl of isopropanol
The color of the mixture will turn yellow after the addition of Buffer DE-B. Please make sure the contents are a uniform yellow color before proceeding.
5. Place a Miniprep column into a 2 ml microfuge tube (provided). Transfer the solubilized agarose from step C4 into the column. Centrifuge at 12,000 x g for 1 min.
6. Discard the filtrate from the 2 ml microfuge tube. Return the Miniprep column to the 2 ml microfuge tube and add 500 μl of Buffer W1. Centrifuge at 12,000 x g for 30 sec.
7. Discard the filtrate from the 2 ml microfuge tube. Return the Miniprep column to the 2 ml microfuge tube and add 700 μl of Buffer W2. Centrifuge at 12,000 x g for 30 sec.
Note: Make sure that 95-100% ethanol has been added into Buffer W2 concentrate.
Make a notation on the bottle label for future reference. 2. Incubate at 42 °C for 90 sec followed by transfering immediately on ice for 3 min.
3. Add 1 ml LB medium, incubate at 37 °C shaker for 1 h.
4. Centrifuge at 8,000 rpm for 2 min at room temperature and throw away the supernatant, use 50 μl LB medium to re-suspend the bacteria precipitate. 6. Put the plate at 37 °C bacteriological incubator for 12-16 h. 7. Ligation products are transformed into the competent E.coli-DH5α as described in step F1-6.
Reagents Volume
8. Extract recombinant plasmid from E.coli-DH5α as described step G. 
